Development and Preliminary Testing of the Withdrawal Assessment Tool-Alpha 2 Agonist: An Assessment Instrument for Monitoring Iatrogenic Withdrawal Symptoms in Children Receiving an Alpha-2 Agonist
Sign Up to like & getrecommendations! Published in 2024 at "Pediatric Critical Care Medicine"
DOI: 10.1097/pcc.0000000000003645
Abstract: OBJECTIVES: To develop and conduct preliminary testing of the Withdrawal Assessment Tool-Alpha 2 Agonist (WAT-A2A) to monitor dexmedetomidine and clonidine withdrawal symptoms in acutely ill children. DESIGN: Three-phase instrument development study. Phase 1: retrospective chart… read more here.
Keywords: withdrawal; wat a2a; alpha agonist; instrument ... See more keywords
A PPAR-alpha agonist and DPP-4 inhibitor mitigate adipocyte dysfunction in obese mice.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of molecular endocrinology"
DOI: 10.1530/jme-21-0084
Abstract: Obesity causes white and brown adipocyte dysfunction, reducing browning and stimulating whitening. Drugs that tackle adipocyte dysfunction through thermogenesis stimulation could be used to treat obesity. This study sought to address whether a combination of… read more here.
Keywords: combination; alpha agonist; dysfunction; adipocyte dysfunction ... See more keywords
Determinants of the risk of intraoperative complications in phacoemulsification among patients with pseudoexfoliation
Sign Up to like & getrecommendations! Published in 2021 at "Saudi Journal of Ophthalmology"
DOI: 10.4103/1319-4534.325774
Abstract: PURPOSE: The purpose of the study was to study the relationship between pseudoexfoliation (PES) and other predictors in the development of complications in cataract surgery by phacoemulsification in patients with PES. METHODS: A retrospective cohort… read more here.
Keywords: determinants risk; alpha agonist; agonist use; phacoemulsification ... See more keywords